您当前所在的位置:首页 > 产品中心 > 产品信息
Succinylcholine_分子结构_CAS_306-40-1)
点击图片或这里关闭

Succinylcholine

产品号 DB00202 公司名称 DrugBank
CAS号 306-40-1 公司网站 http://www.ualberta.ca/
分子式 C14H30N2O4++ 电 话 (780) 492-3111
分子量 290.399 传 真
纯 度 电子邮件 david.wishart@ualberta.ca
保 存 Chembase数据库ID: 87

产品价格信息

请登录

产品别名

标题
Succinylcholine
IUPAC标准名
trimethyl[2-({4-oxo-4-[2-(trimethylazaniumyl)ethoxy]butanoyl}oxy)ethyl]azanium
IUPAC传统名
succinylcholine
商标名
Quelicin Preservative Free
Anectine
Quelicin
Sucostrin
别名
Scoline
Succinylcholine Chloride
Suxamethonium chloride

产品登记号

CAS号 306-40-1
PubChem CID 5314
PubChem SID 46506023

产品性质

产品详细信息

详细说明 (English)
Item Information
Drug Groups approved
Description A quaternary skeletal muscle relaxant usually used in the form of its bromide, chloride, or iodide. It is a depolarizing relaxant, acting in about 30 seconds and with a duration of effect averaging three to five minutes. Succinylcholine is used in surgical, anesthetic, and other procedures in which a brief period of muscle relaxation is called for. [PubChem]
Indication Used in surgical procedures where a rapid onset and brief duration of muscle relaxation is needed (includes intubation, endoscopies, and ECT)
Pharmacology Succinylcholine is indicated as an adjunct to general anesthesia, to facilitate tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation. Succinylcholine is a depolarizing skeletal muscle relaxant. As does acetylcholine, it combines with the cholinergic receptors of the motor end plate to produce depolarization. This depolarization may be observed as fasciculations. Subsequent neuromuscular transmission is inhibited so long as adequate concentration of succinylcholine remains at the receptor site. Succinylcholine has no direct action on the uterus or other smooth muscle structures.
Affected Organisms
Humans and other mammals
Biotransformation By pseudocholinesterase, to succinylmonocholine and choline.
Elimination About 10% of the drug is excreted unchanged in the urine.
References
Jonsson M, Dabrowski M, Gurley DA, Larsson O, Johnson EC, Fredholm BB, Eriksson LI: Activation and inhibition of human muscular and neuronal nicotinic acetylcholine receptors by succinylcholine. Anesthesiology. 2006 Apr;104(4):724-33. [Pubmed]
External Links
Wikipedia
RxList
Drugs.com

参考文献

  • Jonsson M, Dabrowski M, Gurley DA, Larsson O, Johnson EC, Fredholm BB, Eriksson LI: Activation and inhibition of human muscular and neuronal nicotinic acetylcholine receptors by succinylcholine. Anesthesiology. 2006 Apr;104(4):724-33. Pubmed